ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow rise as AI boost counters US-Iran tensions
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
ANI Pharma (ANIP) Tops Q1 EPS by 4c
May 8, 2018 8:32 AM EDTANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $1.32, $0.04 better than the analyst estimate of $1.28. Revenue for the quarter came in at $46.5 million versus the consensus estimate of $49.93 million.
ANI Reaffirms Guidance for the Full Year 2018For earnings history and earnings-related data on ANI Pharma (ANIP) click here.
... More